Why is Senores Pharma. falling/rising?

As of 05-Jun, Senores Pharmaceuticals Ltd is experiencing a price increase, currently at Rs 527.00, reflecting a rise of Rs 13.5 or 2.63%. The stock has outperformed its sector by 1.57% today and reached an intraday high of Rs 535, which is a 4.19% increase. Over the past week, the stock has gained 1.62%, and over the past month, it has risen by 4.56%. However, it is important to note that the stock's year-to-date performance shows a decline of 7.37%. Additionally, there has been a significant drop in investor participation, with delivery volume falling by 44.19% compared to the 5-day average, indicating a potential concern regarding sustained interest in the stock.
In the broader market context, while Senores Pharmaceuticals has shown positive short-term returns, the benchmark Sensex has experienced a slight decline of 0.23% over the past week. The stock's performance today contrasts with the benchmark's performance, suggesting that it is currently attracting more investor interest despite its year-to-date underperformance relative to the Sensex, which has gained 4.23% this year. The liquidity of the stock remains adequate for trading, which may contribute to its recent price rise, although the falling delivery volume could signal caution among investors moving forward.